A detailed history of Walleye Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Walleye Capital LLC holds 156,400 shares of VTRS stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156,400
Previous 80,900 93.33%
Holding current value
$2.03 Million
Previous $859,000 111.29%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $85,005 - $99,914
8,237 Added 255.33%
11,463 $133,000
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $48,611 - $58,140
-4,837 Reduced 59.99%
3,226 $34,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $90,870 - $109,092
8,063 New
8,063 $96,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $710,261 - $810,265
78,743 New
78,743 $785,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $127,726 - $200,508
-13,020 Closed
0 $0
Q4 2021

Mar 03, 2022

BUY
$12.09 - $14.68 $157,411 - $191,133
13,020 New
13,020 $176,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.